2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by GARIBOTTO, G. Articles by BARRECA, T. Search for Related Content PubMed PubMed Citation Articles by GARIBOTTO, G. Articles by BARRECA, T.

Effects of Growth Hormone on Leptin Metabolism and Energy Expenditure in Hemodialysis Patients with Protein-Calorie Malnutrition

GIACOMO GARIBOTTO^*, ANTONINA BARRECA, ANTONELLA SOFIA^*, RODOLFO RUSSO^*, FULVIO FIORINI, GIORGIO CAPPELLI^§, FOSCO CAVATORTA, ARIANNA CESARONE, ROBERTO FRANCESCHINI^*, PAOLO SACCO^*, FRANCESCO MINUTO and TOMASO BARRECA^*

^* Division of Nephrology, Department of Internal Medicine, University of Genoa, Genoa, Italy.
Department of Endocrinology and Metabolism, University of Genoa, Genoa, Italy.
Imperia Hospital, Genoa, Italy.
^§ Sampierdarena Hospital, Genoa, Italy.

Correspondence to Dr. Giacomo Garibotto, Department of Internal Medicine, Nephrology Division, University of Genoa, Viale Benedetto XV^o,6,16132 Genoa, Italy. Phone: + + 39-010-3538989; Fax: + + 39-010-3538638; E-mail: gari{at}unige.it

Abstract. The relationships among growth hormone (GH), leptin, and resting energy expenditure (REE) are not understood. It has been reported that in malnourished hemodialysis patients, GH increases muscle protein synthesis, a process that requires energy. The present study evaluated the arterial levels and the forearm exchange of leptin, as well as the REE of the same patients during their participation in the same study, in four sequential 6-wk periods: I, baseline; II, GH treatment; III, washout; and IV, GH + intradialytic parenteral nutrition. During periods II and IV, patients received GH (5 mg three times per week). REE rose by 5% in period II, declined during period III, and rose by 7% during period IV. Basal leptin levels were low (2.0 ± 0.19 ng/L). Insulin and leptin levels, as well as leptin release from the forearm, were unchanged during periods I through III but rose (+ 36%; P < 0.05) during period IV. Changes in arterial leptin were directly related to changes in forearm leptin release (P < 0.002), indicating a role of leptin production by peripheral tissues on leptinemia. Changes in leptin release were directly related to insulin (P < 0.001) and, less consistently, to insulin-like growth factor-binding protein-1 levels (P < 0.02). Similarly, variations in leptin levels were directly related to insulin (P < 0.01). Variations in REE were not related to variations in leptin or insulin levels but to changes in muscle protein synthesis (P < 0.025). The data show that in malnourished hemodialysis patients, treatment with GH is not invariably associated with an increase in leptin production. An increase in leptin release by peripheral tissues and leptin levels occurs only in the setting of hyperinsulinemia. The increase in REE that is induced by treatment with GH is not dependent on changes in leptin but is largely accounted for by the energy cost of the stimulation of muscle protein synthesis.

This article has been cited by other articles:

				P. Iglesias, J. J. Diez, M J. Fernandez-Reyes, M A. Bajo, A. Aguilera, J. Mendez, R. Codoceo, and R. Selgas Effects of short-term recombinant human growth hormone therapy on plasma leptin concentrations in dialysis patients Nephrol. Dial. Transplant., February 1, 2002; 17(2): 260 - 264. [Abstract] [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673